TW202434198A - 保護腦神經細胞用之組成物 - Google Patents

保護腦神經細胞用之組成物 Download PDF

Info

Publication number
TW202434198A
TW202434198A TW112150593A TW112150593A TW202434198A TW 202434198 A TW202434198 A TW 202434198A TW 112150593 A TW112150593 A TW 112150593A TW 112150593 A TW112150593 A TW 112150593A TW 202434198 A TW202434198 A TW 202434198A
Authority
TW
Taiwan
Prior art keywords
composition
docosahexaenoic acid
acid
lutein
fatty acid
Prior art date
Application number
TW112150593A
Other languages
English (en)
Chinese (zh)
Inventor
森田賢
末安俊明
安本啓甫
Original Assignee
日商三得利控股股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商三得利控股股份有限公司 filed Critical 日商三得利控股股份有限公司
Publication of TW202434198A publication Critical patent/TW202434198A/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Botany (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW112150593A 2022-12-26 2023-12-25 保護腦神經細胞用之組成物 TW202434198A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2022208134 2022-12-26
JP2022-208134 2022-12-26
JP2023-061431 2023-04-05
JP2023061431 2023-04-05

Publications (1)

Publication Number Publication Date
TW202434198A true TW202434198A (zh) 2024-09-01

Family

ID=91717479

Family Applications (1)

Application Number Title Priority Date Filing Date
TW112150593A TW202434198A (zh) 2022-12-26 2023-12-25 保護腦神經細胞用之組成物

Country Status (4)

Country Link
JP (1) JPWO2024143060A1 (enrdf_load_stackoverflow)
CN (1) CN120417894A (enrdf_load_stackoverflow)
TW (1) TW202434198A (enrdf_load_stackoverflow)
WO (1) WO2024143060A1 (enrdf_load_stackoverflow)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015005443A1 (ja) * 2013-07-10 2015-01-15 ライオン株式会社 内服組成物
CN110691590A (zh) * 2017-06-01 2020-01-14 参天制药株式会社 用于预防和/或改善脑功能障碍的含有叶黄素类或其盐和菱属植物的加工产物的组合物
GB201720119D0 (en) * 2017-12-04 2018-01-17 Howard Foundation Holdings Ltd Prevention and/or treatment of neurodegenerative disease

Also Published As

Publication number Publication date
WO2024143060A1 (ja) 2024-07-04
CN120417894A (zh) 2025-08-01
JPWO2024143060A1 (enrdf_load_stackoverflow) 2024-07-04

Similar Documents

Publication Publication Date Title
US8114445B2 (en) Dietary supplement for promoting wellness and weight loss and methods of administering the same
ES2585066T3 (es) Composiciones para el tratamiento de trastornos neurológicos
JP2018534278A (ja) 骨格筋の健康のためポリフェノールを使用する組成物及び方法
CN102355898A (zh) 能量消耗促进剂
RU2771277C2 (ru) Лечение травматического повреждения головного мозга
US20120302645A1 (en) Use of hydroxytyrosol for improving muscle differentiation
JP7429739B2 (ja) ルテイン類またはその塩およびヒシ属植物の加工物を含有する脳機能障害の予防および／または改善用組成物
JP2007238441A (ja) アスタキサンチンを有効成分とする体脂肪減少用組成物
KR101695848B1 (ko) 진세노사이드 f2를 포함하는 비알코올성 간 질환 또는 인슐린 저항성의 예방 또는 치료용 조성물
Rahiman et al. Oleuropein and oleic acid: A novel emerging dietary target for human chronic diseases
CA2961465C (en) Anti-diabetic effects of gypenoside 75
US20200093929A1 (en) Pharmaceutical composition for the prevention and treatment of memory and cognitive deficits related to ageing
TWI879956B (zh) 菸鹼醯胺腺嘌呤二核苷酸（ｎａｄ）濃度上升劑
TWI884198B (zh) 含有芝麻素類及吡咯喹啉醌（ｐｑｑ）之組成物
KR101206543B1 (ko) 율피 추출물을 포함하는 지방간의 예방 또는 치료용 조성물
TW202434198A (zh) 保護腦神經細胞用之組成物
US20200345728A1 (en) Compositions and methods for treatment of atherosclerosis
JP7728274B2 (ja) 抗疲労用組成物及びエネルギー産生能の向上、低下抑制又は維持のための組成物
JP2005082495A (ja) 脳細胞保護のための組成物
EP1915142A1 (en) Composition comprising oleic acid and the use thereof
JP2009107945A (ja) 視神経障害抑制剤及びそれを含有する飲食品
KR100780120B1 (ko) 공액 리놀레산을 함유하는 숙취해소 및 알코올성 질병예방을 위한 기능성 식품
WO2022244867A1 (ja) 認知機能の改善用組成物、認知機能改善剤および認知機能の改善用食品
KR20240094564A (ko) 메틸 리놀레산을 포함하는 지방간 질환의 개선, 예방 또는 치료용 약학적 조성물
KR20240057723A (ko) 일리마퀴논을 포함하는 지방간 질환 예방 또는 치료용 약학적 조성물